Cryptococcus gattii: An emerging fungal pathogen infecting humans and animals

Microbes and Infection

Volumn 13, Issue 11, 2011, Pages 895-907

  Byrnes, Edmond J ^a,c   Bartlett, Karen H ^b   Perfect, John R ^a   Heitman, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptococcosis; Emerging outbreak; Fungal infections; Meningitis; Pulmonary disease

Indexed keywords

FLUCONAZOLE; PYRROLE DERIVATIVE; VIRULENCE FACTOR;

CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECOLOGICAL NICHE; ENDEMIC DISEASE; EPIDEMIC; FATALITY; FUNGAL COLONIZATION; FUNGAL VIRULENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NONHUMAN; PATHOPHYSIOLOGY; POPULATION STRUCTURE; PRIORITY JOURNAL; SEIZURE; SEROLOGY; SHORT SURVEY; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS REACTIVATION;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE OUTBREAKS; ENDEMIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR EPIDEMIOLOGY;

ANIMALIA; CRYPTOCOCCUS GATTII; FUNGI;

EID: 80052426146     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.05.009     Document Type: Short Survey

References (126)

1. Cohen M.L. Changing patterns of infectious disease. Nature 2000, 406:762-767.
2. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430:242-249.
3. Morens D.M., Folkers G.K., Fauci A.S. Emerging infections: a perpetual challenge. Lancet Infect. Dis. 2008, 8:710-719.
4. Fisher M.C., Garner T.W., Walker S.F. Global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time, and host. Annu. Rev. Microbiol. 2009, 63:291-310.
5. Blehert D.S., Hicks A.C., Behr M., Meteyer C.U., Berlowski-Zier B.M., Buckles E.L., Coleman J.T., Darling S.R., Gargas A., Niver R., Okoniewski J.C., Rudd R.J., Stone W.B. Bat white-nose syndrome: an emerging fungal pathogen?. Science 2009, 323:227.
6. Bromenshenk J.J., Henderson C.B., Wick C.H., Stanford M.F., Zulich A.W., Jabbour R.E., Deshpande S.V., McCubbin P.E., Seccomb R.A., Welch P.M., Williams T., Firth D.R., Skowronski E., Lehmann M.M., Bilimoria S.L., Gress J., Wanner K.W., Cramer R.A. Iridovirus and microsporidian linked to honey bee colony decline. PLoS One 2010, 5:e13181.
7. Chen Y., Evans J.D., Smith I.B., Pettis J.S. Nosema ceranae is a long-present and wide-spread microsporidian infection of the European honey bee (Apis mellifera) in the United States. J. Invertebr. Pathol. 2008, 97:186-188.
8. Cornman R.S., Chen Y.P., Schatz M.C., Street C., Zhao Y., Desany B., Egholm M., Hutchison S., Pettis J.S., Lipkin W.I., Evans J.D. Genomic analyses of the microsporidian Nosema ceranae, an emergent pathogen of honey bees. PLoS Pathog. 2009, 5:e1000466.
9. Cox-Foster D.L., Conlan S., Holmes E.C., Palacios G., Evans J.D., Moran N.A., Quan P.L., Briese T., Hornig M., Geiser D.M., Martinson V., vanEngelsdorp D., Kalkstein A.L., Drysdale A., Hui J., Zhai J., Cui L., Hutchison S.K., Simons J.F., Egholm M., Pettis J.S., Lipkin W.I. A metagenomic survey of microbes in honey bee colony collapse disorder. Science 2007, 318:283-287.
10. Perfect J.R. Cryptococcosis. Infect. Dis. Clin. North Am. 1989, 3:77-102.
11. Sorrell T.C. Cryptococcus neoformans variety gattii. Med. Mycol. 2001, 39:155-168.
12. Kwon-Chung K.J., Bennett J.E. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl. Bakteriol. Mikrobiol. Hyg. [A] 1984, 257:213-218.
13. Kwon-Chung K.J., Boekhout T., Fell J.W., Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002, 51:804-806.
14. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
15. Kwon-Chung K.J., Varma A. Do major species concepts support one, two or more species within Cryptococcus neoformans?. FEMS Yeast Res. 2006, 6:574-587.
16. Boekhout T., Theelen B., Diaz M., Fell J.W., Hop W.C., Abeln E.C., Dromer F., Meyer W. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001, 147:891-907.
17. Fraser J.A., Giles S.S., Wenink E.C., Geunes-Boyer S.G., Wright J.R., Diezmann S., Allen A., Stajich J.E., Dietrich F.S., Perfect J.R., Heitman J. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005, 437:1360-1364.
18. Bovers M., Hagen F., Kuramae E.E., Boekhout T. Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet. Biol. 2008, 45:400-421.
19. Byrnes E.J., Bildfell R.J., Frank S.A., Mitchell T.G., Marr K.A., Heitman J. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J. Infect. Dis. 2009, 199:1081-1086.
20. Byrnes E.J., Li W., Lewit Y., Ma H., Voelz K., Ren P., Carter D.A., Chaturvedi V., Bildfell R.J., May R.C., Heitman J. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 2010, 6:e1000850.
21. Byrnes E.J., Li W., Lewit Y., Perfect J.R., Carter D.A., Cox G.M., Heitman J. First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen. PLoS One 2009, 4:e5851.
22. Kidd S.E., Guo H., Bartlett K.H., Xu J., Kronstad J.W. Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryot. Cell 2005, 4:1629-1638.
23. MacDougall L., Kidd S.E., Galanis E., Mak S., Leslie M.J., Cieslak P.R., Kronstad J.W., Morshed M.G., Bartlett K.H. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg. Infect. Dis. 2007, 13:42-50.
24. Byrnes E.J., Heitman J. Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences. F1000 Biology Reports 2009, 1:62.
25. Litvintseva A.P., Thakur R., Reller L.B., Mitchell T.G. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J. Infect. Dis. 2005, 192:888-892.
26. Fisher D., Burrow J., Lo D., Currie B. Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust. N.Z.J. Med. 1993, 23:678-682.
27. Seaton R.A. The management of cryptococcal meningitis in Papua New Guinea. P.N.G. Med. J. 1996, 39:67-73.
28. Seaton R.A., Wembri J.P., Armstrong P., Ombiga J., Naraqi S., Kevau I. Symptomatic human immunodeficiency virus (HIV) infection in Papua New Guinea. Aust. N.Z.J. Med. 1996, 26:783-788.
29. Galanis E., MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg. Infect. Dis. 2010, 16:251-257.
30. Perfect J.R., Dismukes W.E., Dromer F., Goldman D.L., Graybill J.R., Hamill R.J., Harrison T.S., Larsen R.A., Lortholary O., Nguyen M.H., Pappas P.G., Powderly W.G., Singh N., Sobel J.D., Sorrell T.C. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2010, 50:291-322.
31. Byrnes E.J., Bildfell R.J., Dearing P.L., Valentine B.A., Heitman J. Cryptococcus gattii with bimorphic colony types in a dog in western Oregon: additional evidence for expansion of the Vancouver Island outbreak. J. Vet. Diagn. Invest. 2009, 21:133-136.
32. Iqbal N., Debess E.E., Wohrle R., Sun B., Nett R.J., Ahlquist A.M., Chiller T. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii from the Pacific Northwest of the United States. J. Clin. Microbiol. 2009, 48:539-544.
33. Stephen C., Lester S., Black W., Fyfe M., Raverty S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can. Vet. J. 2002, 43:792-794.
34. Duncan C., Schwantje H., Stephen C., Campbell J., Bartlett K. Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada. J. Wildl. Dis. 2006, 42:175-178.
35. Duncan C., Stephen C., Lester S., Bartlett K.H. Sub-clinical infection and asymptomatic carriage of Cryptococcus gattii in dogs and cats during an outbreak of cryptococcosis. Med. Mycol. 2005, 43:511-516.
36. Malik R., Alderton B., Finlaison D., Krockenberger M.B., Karaoglu H., Meyer W., Martin P., France M.P., McGill J., Lester S.J., O'Brien C.R., Love D.N. Cryptococcosis in ferrets: a diverse spectrum of clinical disease. Aust. Vet. J. 2002, 80:749-755.
37. Miller W.G., Padhye A.A., van Bonn W., Jensen E., Brandt M.E., Ridgway S.H. Cryptococcosis in a bottlenose dolphin (Tursiops truncatus) caused by Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 2002, 40:721-724.
38. Duncan C., Bartlett K.H., Lester S., Bobsien B., Campbell J., Stephen C., Raverty S. Surveillance for Cryptococcus gattii in horses of Vancouver Island, British Columbia, Canada. Med. Mycol. 2011, 7:1-5. 10.3109/13693786.2011.560196.
39. Lester S.J., Kowalewich N.J., Bartlett K.H., Krockenberger M.B., Fairfax T.M., Malik R. Clinicopathologic features of an unusual outbreak of cryptococcosis in dogs, cats, ferrets, and a bird: 38 cases (January to July 2003). J. Am. Vet. Med. Assoc. 2004, 225:1716-1722.
40. Lester S.J., Malik R., Bartlett K.H., Duncan C.G. Cryptococcosis: update and emergence of Cryptococcus gattii. Vet. Clin. Pathol 2011, 40:4-17.
41. Kidd S.E., Hagen F., Tscharke R.L., Huynh M., Bartlett K.H., Fyfe M., Macdougall L., Boekhout T., Kwon-Chung K.J., Meyer W. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17258-17263.
42. Meyer W., Marszewska K., Amirmostofian M., Igreja R.P., Hardtke C., Methling K., Viviani M.A., Chindamporn A., Sukroongreung S., John M.A., Ellis D.H., Sorrell T.C. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999, 20:1790-1799.
43. Meyer W., Castaneda A., Jackson S., Huynh M., Castaneda E. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg. Infect. Dis. 2003, 9:189-195.
44. Ellis D., Marriott D., Hajjeh R.A., Warnock D., Meyer W., Barton R. Epidemiology: surveillance of fungal infections. Med. Mycol. 2000, 38(Suppl. 1):173-182.
45. Fraser J.A., Subaran R.L., Nichols C.B., Heitman J. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryot. Cell 2003, 2:1036-1045.
46. Chaturvedi S., Dyavaiah M., Larsen R.A., Chaturvedi V. Cryptococcus gattii in AIDS patients, southern California. Emerg. Infect. Dis. 2005, 11:1686-1692.
47. Litvintseva A.P., Thakur R., Vilgalys R., Mitchell T.G. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 2006, 172:2223-2238.
48. Meyer W., Aanensen D.M., Boekhout T., Cogliati M., Diaz M.R., Esposto M.C., Fisher M., Gilgado F., Hagen F., Kaocharoen S., Litvintseva A.P., Mitchell T.G., Simwami S.P., Trilles L., Viviani M.A., Kwon-Chung J. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med. Mycol. 2009, 47:561-570.
49. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., Zhang Q., Zhou J., Zurth K., Caugant D.A., Feavers I.M., Achtman M., Spratt B.G. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3140-3145.
50. Upton A., Fraser J.A., Kidd S.E., Bretz C., Bartlett K.H., Heitman J., Marr K.A. First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak. J. Clin. Microbiol. 2007, 45:3086-3088.
51. Lindberg J., Hagen F., Laursen A., Stenderup J., Boekhout T. Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada. Emerg. Infect. Dis. 2007, 13:178-179.
52. Georgi A., Schneemann M., Tintelnot K., Calligaris-Maibach R.C., Meyer S., Weber R., Bosshard P.P. Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection 2009, 37:370-373.
53. Hagen F., Assen S.V., Luijckx G.J., Boekhout T., Kampinga G.A. Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach. Med. Mycol. 2009, 48:528-531.
54. Okamoto K., Hatakeyama S., Itoyama S., Nukui Y., Yoshino Y., Kitazawa T., Yotsuyanagi H., Ikeda R., Sugita T., Koike K. Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg. Infect. Dis. 2010, 16:1155-1157.
55. Halliday C.L., Carter D.A. Clonal reproduction and limited dispersal in an environmental population of Cryptococcus neoformans var gattii isolates from Australia. J. Clin. Microbiol. 2003, 41:703-711.
56. Saul N., Krockenberger M., Carter D. Evidence of recombination in mixed-mating-type and alpha-only populations of Cryptococcus gattii sourced from single eucalyptus tree hollows. Eukaryot. Cell 2008, 7:727-734.
57. Campbell L.T., Currie B.J., Krockenberger M., Malik R., Meyer W., Heitman J., Carter D. Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot. Cell 2005, 4:1403-1409.
58. Campbell L.T., Fraser J.A., Nichols C.B., Dietrich F.S., Carter D., Heitman J. Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot. Cell 2005, 4:1410-1419.
59. Kidd S.E., Chow Y., Mak S., Bach P.J., Chen H., Hingston A.O., Kronstad J.W., Bartlett K.H. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl. Environ. Microbiol. 2007, 73:1433-1443.
60. Sampaio J.P., Inacio J., Fonseca A., Gadanho M., Spencer-Martins I., Scorzetti G., Fell J.W. Auriculibuller fuscus gen. nov., sp. nov. and Bullera japonica sp. nov., novel taxa in the Tremellales. Int. J. Syst. Evol. Microbiol. 2004, 54:987-993.
61. Ergin C., Ilkit M., Kaftanoglu O. Detection of Cryptococcus neoformans var. grubii in honeybee (Apis mellifera) colonies. Mycoses 2004, 47:431-434.
62. Rimek D., Haase G., Luck A., Casper J., Podbielski A. First report of a case of meningitis caused by Cryptococcus adeliensis in a patient with acute myeloid leukemia. J. Clin. Microbiol. 2004, 42:481-483.
63. Findley K., Rodriguez-Carres M., Metin B., Kroiss J., Fonseca A., Vilgalys R., Heitman J. Phylogeny and phenotypic characterization of pathogenic Cryptococcus species and closely related saprobic taxa in the Tremellales. Eukaryot. Cell 2009, 8:353-361.
64. Gezuele E., Calegari L., Sanabŕa D., Davel G., Civila E. Isolation in Uruguay of Cryptococcus neoformans var. gattii from nest of the wasp Polybia occidentalis. Revista Iberoamericana de Micoloǵa 1993, 10:5-6.
65. Kidd S.E., Sorrell T.C., Meyer W. Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med. Mycol. 2003, 41:171-176.
66. Fuchs B.B., Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr. Opin. Microbiol. 2006, 9:346-351.
67. London R., Orozco B.S., Mylonakis E. The pursuit of cryptococcal pathogenesis: heterologous hosts and the study of cryptococcal host-pathogen interactions. FEMS Yeast Res. 2006, 6:567-573.
68. Mylonakis E., Moreno R., El Khoury J.B., Idnurm A., Heitman J., Calderwood S.B., Ausubel F.M., Diener A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 2005, 73:3842-3850.
69. Velagapudi R., Hsueh Y.P., Geunes-Boyer S., Wright J.R., Heitman J. Spores as infectious propagules of Cryptococcus neoformans. Infect. Immun. 2009, 77:4345-4355.
70. Goldman D.L., Khine H., Abadi J., Lindenberg D.J., Pirofski L., Niang R., Casadevall A. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001, 107:E66.
71. Ellis D.H. Cryptococcus neoformans var. gattii in Australia. J. Clin. Microbiol. 1987, 25:430-431.
72. Pfeiffer T., Ellis D. Environmental isolation of Cryptococcus neoformans var. gattii from California. J. Infect. Dis. 1991, 163:929-930.
73. Ellis D.H., Pfeiffer T.J. Natural habitat of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 1990, 28:1642-1644.
74. Pfeiffer T.J., Ellis D.H. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J. Med. Vet. Mycol. 1992, 30:407-408.
75. Seaton R.A., Hamilton A.J., Hay R.J., Warrell D.A. Exposure to Cryptococcus neoformans var. gattii-a seroepidemiological study. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:508-512.
76. Laurenson I.F., Lalloo D.G., Naraqi S., Seaton R.A., Trevett A.J., Matuka A., Kevau I.H. Cryptococcus neoformans in Papua New Guinea: a common pathogen but an elusive source. J. Med. Vet. Mycol. 1997, 35:437-440.
77. Bartlett K.H., Kidd S.E., Kronstad J.W. The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Curr. Infect. Dis. Rep. 2008, 10:58-65.
78. Datta K., Bartlett K.H., Baer R., Byrnes E., Galanis E., Heitman J., Hoang L., Leslie M.J., MacDougall L., Magill S.S., Morshed M.G., Marr K.A. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg. Infect. Dis. 2009, 15:1185-1191.
79. MacDougall L., Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J. Clin. Microbiol. 2006, 44:1851-1852.
80. Duncan C.G., Stephen C., Campbell J. Evaluation of risk factors for Cryptococcus gattii infection in dogs and cats. J. Am. Vet. Med. Assoc. 2006, 228:377-382.
81. Mak S., Klinkenberg B., Bartlett K., Fyfe M. Ecological niche modeling of Cryptococcus gattii in British Columbia, Canada. Environ. Health. Perspect. 2010, 118:653-658.
82. Nicol A.M., Hurrell C., McDowall W., Bartlett K., Elmieh N. Communicating the risks of a new, emerging pathogen: the case of Cryptococcus gattii. Risk. Anal. 2008, 28:373-386.
83. Chambers C., MacDougall L., Li M., Galanis E. Tourism and specific risk areas for Cryptococcus gattii, Vancouver Island, Canada. Emerg. Infect. Dis. 2008, 14:1781-1783.
84. D'Souza C.A., Kronstad J.W., Taylor G., Warren R., Yuen M., Hu G., Jung W.H., Sham A., Kidd S.E., Tangen K., Lee N., Zeilmaker T., Sawkins J., McVicker G., Shah S., Gnerre S., Griggs A., Zeng Q., Bartlett K., Li W., Wang X., Heitman J., Stajich J.E., Fraser J.A., Meyer W., Carter D., Schein J., Krzywinski M., Kwon-Chung K.J., Varma A., Wang J., Brunham R., Fyfe M., Ouellette B.F., Siddiqui A., Marra M., Jones S., Holt R., Birren B.W., Galagan J.E., Cuomo C.A. Genome variation in Cryptococcus gattii, an emerging pathogen of Immunocompetent hosts. MBio 2011, 2. e00342-10.
85. Beatty J.A., Barrs V.R., Swinney G.R., Martin P.A., Malik R. Peripheral vestibular disease associated with cryptococcosis in three cats. J. Feline. Med. Surg. 2000, 2:29-34.
86. Begg L.M., Hughes K.J., Kessell A., Krockenberger M.B., Wigney D.I., Malik R. Successful treatment of cryptococcal pneumonia in a pony mare. Aust. Vet. J. 2004, 82:686-692.
87. Duncan C., Stephen C., Campbell J. Clinical characteristics and predictors of mortality for Cryptococcus gattii infection in dogs and cats of southwestern British Columbia. Can. Vet. J. 2006, 47:993-998.
88. Duncan C., Stephen C., Lester S., Bartlett K.H. Follow-up study of dogs and cats with asymptomatic Cryptococcus gattii infection or nasal colonization. Med. Mycol. 2005, 43:663-666.
89. Malik R., Martin P., McGill J., Martin A., Love D.N. Successful treatment of invasive nasal cryptococcosis in a ferret. Aust. Vet. J. 2000, 78:158-159.
90. Morgan J., McCarthy K.M., Gould S., Fan K., Arthington-Skaggs B., Iqbal N., Stamey K., Hajjeh R.A., Brandt M.E. Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin. Infect. Dis. 2006, 43:1077-1080.
91. Krockenberger M.B., Canfield P.J., Malik R. Cryptococcus neoformans var. gattii in the koala (Phascolarctos cinereus): a review of 43 cases of cryptococcosis. Med. Mycol. 2003, 41:225-234.
92. Chen S., Sorrell T., Nimmo G., Speed B., Currie B., Ellis D., Marriott D., Pfeiffer T., Parr D., Byth K. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin. Infect. Dis. 2000, 31:499-508.
93. Mitchell D.H., Sorrell T.C., Allworth A.M., Heath C.H., McGregor A.R., Papanaoum K., Richards M.J., Gottlieb T. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin. Infect. Dis. 1995, 20:611-616.
94. Speed B., Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 1995, 21:28-34. discussion 35-26.
95. Thompson G.R., Wiederhold N.P., Fothergill A.W., Vallor A.C., Wickes B.L., Patterson T.F. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob. Agents. Chemother. 2009, 53:309-311.
96. Torres-Rodriguez J.M., Alvarado-Ramirez E., Murciano F., Sellart M. MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii. J. Antimicrob. Chemother. 2008, 62:205-206.
97. Cheng P.Y., Sham A., Kronstad J.W. Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect. Immun. 2009, 77:4284-4294.
98. Steele K.T., Thakur R., Nthobatsang R., Steenhoff A.P., Bisson G.P. In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and infection in Gaborone, Botswana. Med. Mycol. 2010, 48:1112-1115.
99. CDC Emergence of Cryptococcus gattii- Pacific Northwest, 2004-2010. Morb. Mortal. Wkly. Rep. 2010, 59:865-868.
100. Sorrell T.C., Chen S.C.A., Phillips P., Marr K.A. Clinical perspectives on Cryptococcus neoformans and Cryptococcus gattii: implications for diagnosis and management. Cryptococcus: From Human Pathogen to Model Yeast 2011, 595-606. ASM Press, Washington, DC. J. Heitman, T. Kozel, J. Kwon-Chung, J.R. Perfect, A. Casadevall (Eds.).
101. Dromer F., Ronin O., Dupont B. Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J. Med. Vet. Mycol. 1992, 30:395-397.
102. Kluger E.K., Karaoglu H.K., Krockenberger M.B., Della Torre P.K., Meyer W., Malik R. Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a Birman cat. Med. Mycol. 2006, 44:561-566.
103. Ngamskulrungroj P., Himmelreich U., Breger J.A., Wilson C., Chayakulkeeree M., Krockenberger M.B., Malik R., Daniel H.M., Toffaletti D., Djordjevic J.T., Mylonakis E., Meyer W., Perfect J.R. The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii. Infect. Immun. 2009, 77:4584-4596.
104. Petzold E.W., Himmelreich U., Mylonakis E., Rude T., Toffaletti D., Cox G.M., Miller J.L., Perfect J.R. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect. Immun. 2006, 74:5877-5887.
105. Hagen F., Illnait-Zaragozi M.T., Bartlett K.H., Swinne D., Geertsen E., Klaassen C.H., Boekhout T., Meis J.F. In vitro antifungal susceptibilities and AFLP genotyping of a worldwide collection of 350 clinical, veterinary and environmental Cryptococcus gattii isolates. Antimicrob. Agents. Chemother. 2010, 54:5139-5145.
106. McGill S., Malik R., Saul N., Beetson S., Secombe C., Robertson I., Irwin P. Cryptococcosis in domestic animals in Western Australia: a retrospective study from 1995-2006. Med. Mycol. 2009, 47:625-639.
107. Barrs V.R., Allan G.S., Martin P., Beatty J.A., Malik R. Feline pyothorax: a retrospective study of 27 cases in Australia. J. Feline. Med. Surg. 2005, 7:211-222.
108. Bui T., Lin X., Malik R., Heitman J., Carter D. Isolates of Cryptococcus neoformans from infected animals reveal genetic exchange in unisexual, alpha mating type populations. Eukaryot. Cell 2008, 7:1771-1780.
109. Rotstein D.S., West K., Levine G., Lockhart S.R., Raverty S., Morshed M.G., Rowles T. Cryptococcus gattii VGI in a spinner dolphin (Stenella longirostris) from Hawaii. J. Zoo Wildl. Med. 2010, 41:181-183.
110. Cryptococcus neoformans 1998, ASM Press, Washington, DC. A. Casadevall, J.R. Perfect (Eds.).
111. Kwon-Chung K.J., Bennett J.E. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am. J. Epidemiol. 1984, 120:123-130.
112. Lin X., Hull C.M., Heitman J. Sexual reproduction between partners of the same mating type in Cryptococcus neoformans. Nature 2005, 434:1017-1021.
113. Lin X., Litvintseva A.P., Nielsen K., Patel S., Floyd A., Mitchell T.G., Heitman J. alphaADalpha hybrids of Cryptococcus neoformans: evidence of same-sex mating in nature and hybrid fitness. PLoS Genet. 2007, 3:1975-1990.
114. Lin X., Patel S., Litvintseva A.P., Floyd A., Mitchell T.G., Heitman J. Diploids in the Cryptococcus neoformans serotype A population homozygous for the alpha mating type originate via unisexual mating. PLoS Pathog 2009, 5:e1000283.
115. Escandon P., Sanchez A., Martinez M., Meyer W., Castaneda E. Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res. 2006, 6:625-635.
116. Ngamskulrungroj P., Sorrell T.C., Chindamporn A., Chaiprasert A., Poonwan N., Meyer W. Association between fertility and molecular sub-type of global isolates of Cryptococcus gattii molecular type VGII. Med. Mycol. 2008, 1-9.
117. Macdougall L., Fyfe M., Romney M., Starr M., Galanis E. Risk Factors for Cryptococcus gattii Infection, British Columbia, Canada. Emerg. Infect. Dis. 2011, 17:193-199.
118. Bodasing N., Seaton R.A., Shankland G.S., Kennedy D. Cryptococcus neoformans var. gattii meningitis in an HIV-positive patient: first observation in the United Kingdom. J. Infect. 2004, 49:253-255.
119. Bovers M., Hagen F., Kuramae E.E., Boekhout T. Promiscuous mitochondria in Cryptococcus gattii. FEMS Yeast Res. 2009, 9:489-503.
120. Xu J., Yan Z., Guo H. Divergence, hybridization, and recombination in the mitochondrial genome of the human pathogenic yeast Cryptococcus gattii. Mol. Ecol. 2009, 18:2628-2642.
121. Ma H., Hagen F., Stekel D.J., Johnston S.A., Sionov E., Falk R., Polacheck I., Boekhout T., May R.C. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12980-12985.
122. Xu J., Ali R.Y., Gregory D.A., Amick D., Lambert S.E., Yoell H.J., Vilgalys R.J., Mitchell T.G. Uniparental mitochondrial transmission in sexual crosses in Cryptococcus neoformans. Curr. Microbiol. 2000, 40:269-273.
123. Yan Z., Hull C.M., Sun S., Heitman J., Xu J. The mating type-specific homeodomain genes SXI1alpha and SXI2 a coordinately control uniparental mitochondrial inheritance in Cryptococcus neoformans. Curr. Genet. 2007, 51:187-195.
124. Escandon P., Sanchez A., Firacative C., Castaneda E. Isolation of Cryptococcus gattii molecular type VGIII, from Corymbia ficifolia detritus in Colombia. Med. Mycol. 2010, 48:675-678.
125. Callejas A., Ordonez N., Rodriguez M.C., Castaneda E. First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colombia. Med. Mycol. 1998, 36:341-344.
126. Springer D.J., Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg. Infect. Dis. 2010, 16:14-20.